iShares MSCI Pacific ex Japan ETF·Financial Services

Asia-Pacific equities outside Japan have quietly delivered one of the stronger performances among developed-market ETFs over the past year, and most retirees haven't noticed.

JPMorgan Chase and Co. cut its stake in iShares MSCI Pacific ex Japan ETF (NYSEARCA:EPP) by 2.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,912,109 shares of the company's stock after selling 197,114 shares during the quarter. JPMorgan

WATERTOWN, Mass., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced that the U.S. Food and Drug Administration (FDA) today issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for bitopertin as a treatment for patients with erythropoietic protoporphyria (EPP). Bitopertin has been under review for accelerated approval and as part of the Commissioner's National Priority Voucher (CNPV) pilot program.

Shares of iShares MSCI Pacific ex Japan ETF (NYSEARCA:EPP - Get Free Report) reached a new 52-week high during mid-day trading on Friday. The company traded as high as $52.77 and last traded at $52.7450, with a volume of 56324 shares. The stock had previously closed at $52.38. iShares MSCI Pacific ex Japan ETF
The iShares MSCI Pacific ex Japan ETF seeks to track the investment results of an index composed of Pacific region developed market equities, excluding Japan.
Financial Services
Asset Management
2001-10-26
0.98